RxDoctor Payments Data

Roohi Desai, MD

Family Medicine · Saint Louis, MONPI 1770533184

Payments from drug & device makers

$5,131in general payments, 2019–2025

Across 307 payments — averaging $16.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$633
  • Novo Nordisk$626
  • AstraZeneca$564
  • GSK$490
  • Pfizer$402
  • Amgen$350
  • plus $2K from 32 others

What the payments were for

  • Food & beverage$5,131100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,131 in reported general payments places this provider in the 85th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$56,394
Medicare patients
182
Services billed
597

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban132$112,781
Trelegy ElliptaFluticasone/Umeclidin/Vilanter102$80,280
MounjaroTirzepatide35$43,181
JardianceEmpagliflozin34$41,707
ProliaDenosumab24$40,714
MyrbetriqMirabegron44$29,307
ArexvyRsvpref3 Antigen/As01e/Pf109$28,702
OzempicSemaglutide22$28,261
Breztri AerosphereBudesonide/Glycopyr/Formoterol28$17,667
Breo ElliptaFluticasone/Vilanterol37$17,102
FarxigaDapagliflozin Propanediol15$14,116
Combivent RespimatIpratropium/Albuterol Sulfate11$9,241
Atorvastatin Calcium871$7,922
Semglee (Yfgn) PenInsulin Glargine-Yfgn16$6,835
Gabapentin323$6,510

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Arexvy, Breo Ellipta$490$126,085248 claims
PfizerEliquis$402$112,781132 claims
Boehringer IngelheimJardiance, Combivent Respimat$99$50,94845 claims
Lilly USA, LLCMounjaro$633$43,18135 claims
AmgenProlia$350$40,71424 claims
AstraZenecaBreztri Aerosphere, Farxiga, Symbicort$564$36,50857 claims
Astellas Pharma US IncMyrbetriq$83$29,30744 claims
Novo NordiskOzempic$626$28,26122 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →